FDA Adverse Event Injury Summary report: N

VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HIV 1+2 CONTROLS

MDR report key: 4430316 · Received January 19, 2015

Report

Report Number
3007111389-2015-00018
Event Type
Injury
Date Received
January 19, 2015
Date of Event
January 2, 2015
Report Date
January 19, 2015
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
JJX
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PK
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION CONCLUDES THAT AN OPERATOR SPLASHED (B)(6) CONTROL FLUID IN THEIR EYE WHILE HANDLING THE PRODUCT. THE ROOT CAUSE OF THIS EVENT IS MOST LIKELY USER ERROR. THE WARNINGS AND PRECAUTIONS SECTION OF THE VITROS IMMUNODIAGNOSTIC PRODUCTS (B)(6)CONTROLS INSTRUCTIONS FOR USE (IFU) STATE: "WARNING: POTENTIALLY INFECTIOUS MATERIAL. HANDLE AS IF CAPABLE OF TRANSMITTING INFECTION. THE VITROS (B)(6)1+2 CONTROLS 2 AND 3 CONTAIN (B)(6) PLASMA OBTAINED FROM DONORS WHO WERE TESTED INDIVIDUALLY AND WHO WERE FOUND TO BE NEGATIVE FOR (B)(6) SURFACE ANTIGEN (B)(6), AND FOR ANTIBODIES TO (B)(6), USING FDA APPROVED METHODS (ENZYME IMMUNOASSAYS, EIA). THE (B)(6) PLASMA HAS BEEN HEAT TREATED TO INACTIVATE VIRUSES.¿

Description of Event or Problem · 1

A CUSTOMER REPORTED THAT AN OPERATOR SPLASHED VITROS IMMUNODIAGNOSTIC PRODUCTS (B)(6) CONTROL INTO HIS EYE WHILE HANDLING THE PRODUCT. THIS EVENT CONSTITUTES BIOHAZARD EXPOSURE. THERE WAS NO ALLEGATION OF OPERATOR HARM AS A RESULT OF THIS EVENT. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC.(B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
44383 VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HIV 1+2 CONTROLS IN-VITRO DIAGNOSTIC JJX ORTHO-CLINICAL DIAGNOSTICS UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1